Abstract
Human microbiome is known to play a key role in human health along with the host genetic makeup and environmental factors. Research studies carried out in the past decade have now established a clear association of human microbiome with various metabolic and gastrointestinal diseases through the state of dysbiosis. Extensive efforts have been made to develop novel and effective methods such as the use of probiotics and fecal microbiota transplantation (FMT) as corrective measures to improve the human health. It is indeed now important to understand the concepts and developmental process of such alternative biotherapeutics to develop potential treatment regimens. This chapter gives insights into the history, development, and the current scenario of the use of these techniques. The process of how these techniques have been developed through mining of the human microbiome is discussed broadly.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abriouel H, Lerma LL, Casado Munõz Mdel C, Montoro BP, Kabisch J, Pichner R et al (2015) The controversial nature of the Weissella genus: technological and functional aspects versus whole genome analysis-based pathogenic potential for their application in food and health. Front Microbiol 6(OCT):1–14. https://doi.org/10.3389/fmicb.2015.01197
Ahmad OF, Akbar A (2016) Microbiome, antibiotics and irritable bowel syndrome. Br Med Bull 120(1):91–99. https://doi.org/10.1093/bmb/ldw038
Alemka A, Clyne M, Shanahan F, Tompkins T, Corcionivoschi N, Bourke B (2010) Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates campylobacter jejuni virulence properties. Infect Immun 78(6):2812–2822. https://doi.org/10.1128/IAI.01249-09
Allegretti J, Eysenbach LM, El-Nachef N, Fischer M, Kelly C, Kassam Z (2017) The current landscape and lessons from fecal microbiota transplantation for inflammatory bowel disease: past, present, and future. Inflamm Bowel Dis 23(10):1710–1717. https://doi.org/10.1097/MIB.0000000000001247
Amara AA, Shibl A (2015) Role of probiotics in health improvement, infection control and disease treatment and management. Saudi Pharm J 23(2):107–114. https://doi.org/10.1016/j.jsps.2013.07.001
Aminov RI (2010) A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 1(DEC):1–7. https://doi.org/10.3389/fmicb.2010.00134
Anandharaj M, Sivasankari B, Santhanakaruppu R, Manimaran M, Rani RP, Sivakumar S (2015) Determining the probiotic potential of cholesterol-reducing Lactobacillus and Weissella strains isolated from gherkins (fermented cucumber) and south Indian fermented koozh. Res Microbiol 166(5):428–439. https://doi.org/10.1016/j.resmic.2015.03.002
De Angelis M, Rizzello CG, Fasano A, Clemente MG, De Simone C, Silano M et al (2006) VSL#3 probiotic preparation has the capacity to hydrolyze gliadin polypeptides responsible for celiac sprue. Biochim Biophys Acta Mol basis Dis 1762(1):80–93. https://doi.org/10.1016/j.bbadis.2005.09.008
Anukam KC, Reid G (2007) Probiotics: 100 years (1907–2007) after Elie Metchnikoff’s observation brief history of Elie Metchnikoff probiotics beyond fermented dairy products. Commun Curr Res Educ Top Trends Appl Microbiol:466–474
Arboleya S, González S, Salazar N, Ruas-Madiedo P, de los Reyes-Gavilán CG, Gueimonde M (2012) Development of probiotic products for nutritional requirements of specific human populations. Eng Life Sci 12(4):368–376. https://doi.org/10.1002/elsc.201100129
Arief II, Afiyah DN, Wulandari Z, Budiman C (2016) Physicochemical properties, fatty acid profiles, and sensory characteristics of fermented beef sausage by probiotics Lactobacillus plantarum IIA-2C12 or Lactobacillus acidophilus IIA-2B4. J Food Sci 81(11):M2761–M2769. https://doi.org/10.1111/1750-3841.13509
Armas F, Camperio C, Marianelli C (2017) In vitro assessment of the probiotic potential of Lactococcus lactis LMG 7930 against ruminant mastitis-causing pathogens. PLoS One 12(1):1–13. https://doi.org/10.1371/journal.pone.0169543
Aroniadis OC, Brandt LJ (2013) Fecal microbiota transplantation: past, present and future. Curr Opin Gastroenterol 29(1):79–84. https://doi.org/10.1097/MOG.0b013e32835a4b3e
Arroyo R, Martín V, Maldonado A, Jiménez E, Fernández L, Rodríguez JM (2010) Treatment of infectious mastitis during lactation: antibiotics versus Oral Administration of Lactobacilli Isolated from breast Milk. Clin Infect Dis 50(12):1551–1558. https://doi.org/10.1086/652763
Bachmayer K (2012) Ulcerative colitis. N Engl J Med 366(9):861–862.; author reply 862-3. https://doi.org/10.1056/NEJMc1113995#SA2
Bakken JS (2009) Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 15(6):285–289. https://doi.org/10.1016/j.anaerobe.2009.09.007
Bakshi A, Stephen S, Borum ML, Doman DB (2012) Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet. Gastroenterol Hepatol 8(9):582–588
Baldi A, Arora M (2015) Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization. Indian J Med Microbiol 33(5):2. https://doi.org/10.4103/0255-0857.150868
Baquero F, Nombela C (2012) The microbiome as a human organ. Clin Microbiol Infect 18(SUPPL. 4):2–4. https://doi.org/10.1111/j.1469-0691.2012.03916.x
Bassols J, Serino M, Carreras-Badosa G, Burcelin R, Blasco-Baque V, Lopez-Bermejo A, Fernandez-Real JM (2016) Gestational diabetes is associated with changes in placental microbiota and microbiome. Pediatr Res 80(6):777–784. https://doi.org/10.1038/pr.2016.155
Ben-Shachar R, Chen Y, Luo S, Hartman C, Reed M, Nijhout HF (2012) The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model. Theor Biol Med Model 9(1). https://doi.org/10.1186/1742-4682-9-55
Bennet JD, Brinkman M (1989) Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. https://doi.org/10.1016/S0140-6736(89)91183-5
Bennet SMP, Öhman L, Simrén M (2015) Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver 9(3):318–331
Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A (2012) Probiotic mechanisms of action. Ann Nutr Metab 61(2):160–174. https://doi.org/10.1159/000342079
Bernardeau M, Guguen M, Vernoux JP (2006) Beneficial lactobacilli in food and feed: long-term use, biodiversity and proposals for specific and realistic safety assessments. FEMS Microbiol Rev 30(4):487–513. https://doi.org/10.1111/j.1574-6976.2006.00020.x
Bernardeau M, Vernoux J-P (2013) Overview of differences between microbial feed additives and probiotics for food regarding regulation, growth promotion effects and health properties and consequences for extrapolation of farm animal results to humans. Clin Microbiol Infect 19(4):321–330. https://doi.org/10.1111/1469-0691.12130
Bernet MF, Brassart D, Neeser JR, Servin AL (1993) Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol 59(12):4121–4128
Bharucha AE, Chakraborty S, Sletten CD (2017) Common functional gastroenterologic disorders associated with abdominal pain. Mayo Clin Proc 4(11):1118–1132. https://doi.org/10.1016/S2214-109X(16)30265-0.Cost-effectiveness
Bhute S, Pande P, Shetty SA, Shelar R, Mane S, Kumbhare SV et al (2016) Molecular characterization and meta-analysis of gut microbial communities illustrate enrichment of prevotella and megasphaera in Indian subjects. Front Microbiol 7(MAY):1–14. https://doi.org/10.3389/fmicb.2016.00660
Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M et al (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100(7):1539–1546. https://doi.org/10.1111/j.1572-0241.2005.41794.x
Bischoff SC, Barbara G, Buurman W, Ockhuizen T, Schulzke J-D, Serino M et al (2014) Intestinal permeability – a new target for disease prevention and therapy. BMC Gastroenterol 14(1):189. https://doi.org/10.1186/s12876-014-0189-7
Bouchachia S, Bessam HM (2016) Knowledge of the digestive microflora: evaluation of breastfeeding on the establishment of the gut microbiota of the newborn. J Food Nutr Sci 4(4):86–90. https://doi.org/10.11648/j.jfns.20160404.12
Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T et al (2012) Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent clostridium difficile infection. Am J Gastroenterol 107(7):1079–1087. https://doi.org/10.1038/ajg.2012.60
Brodmann T, Endo A, Gueimonde M, Vinderola G, Kneifel W, de Vos WM et al (2017) Safety of novel microbes for human consumption: practical examples of assessment in the European Union. Front Microbiol 8(SEP):1–15. https://doi.org/10.3389/fmicb.2017.01725
Bron PA, Kleerebezem M, Brummer R-J, Cani PD, Mercenier A, MacDonald TT et al (2017) Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr 117(01):93–107. https://doi.org/10.1017/S0007114516004037
Brown AC, Valiere A (2006) Probiotics and medical nutrition therapy. Nutr Clin Care 7(2):56–68
Brown KA, Khanafer N, Daneman N, Fisman DN (2013) Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother 57(5):2326–2332. https://doi.org/10.1128/AAC.02176-12
Büchler AC, Rampini SK, Stelling S, Ledergerber B, Peter S, Schweiger A et al (2014) Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich. BMC Infect Dis 14(1):607. https://doi.org/10.1186/s12879-014-0607-z
Calame W, Weseler AR, Viebke C, Flynn C (2018) Gum arabic establishes prebiotic functionality in healthy human volunteers in a dose-dependent manner:1269–1275. https://doi.org/10.1017/S0007114508981447
Camilleri M, CHOI M-G (1997) Review article: irritable bowel syndrome. Aliment Pharmacol Ther 11(1):3–15. https://doi.org/10.1046/j.1365-2036.1997.84256000.x
Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R et al (2017) European consensus conference on faecal microbiota transplantation in clinical practice. Gut 66(4):569–580. https://doi.org/10.1136/gutjnl-2016-313017
Campbell JI, Kanters S, Bennett JE, Thorlund K, Tsai AC, Mills EJ, Siedner MJ (2015) Comparative effectiveness of induction therapy for human immunodeficiency virus-associated Cryptococcal meningitis: a network meta-analysis. Ofid 2(Suppl 1):1–8. https://doi.org/10.1093/ofid/ofv010
Canavan C, West J, Card T (2015) Change in quality of life for patients with irritable bowel syndrome following referral to a gastroenterologist: a cohort Study. PLoS One 10(10):e0139389. https://doi.org/10.1371/journal.pone.0139389
Cani PD, de Vos WM (2017) Next-generation beneficial microbes: the case of Akkermansia muciniphila. Front Microbiol 8(SEP):1–8. https://doi.org/10.3389/fmicb.2017.01765
Card T, Canavan C, West J (2014) The epidemiology of irritable bowel syndrome. Clin Epidemiol 6(1):71. https://doi.org/10.2147/CLEP.S40245
Cassanego D, Richnards N, Valenete P, Mazutti M, Ramirez-Castrillion M, Cassanego D et al (2017) Identification by PCR and evaluation of probiotic potential in yeast strains found in kefir samples in the city of Santa Maria, RS, Brazil. Food SciTechnol (0):0–0. https://doi.org/10.1590/1678-457x.13617
Cénit MC, Matzaraki V, Tigchelaar EF, Zhernakova A (2014) Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochim Biophys Acta Mol basis Dis 1842(10):1981–1992. https://doi.org/10.1016/j.bbadis.2014.05.023
Choi HH, Cho Y-S (2016) Fecal microbiota transplantation: current applications, effectiveness, and future perspectives. Clin Endosc 49(3):257–265. https://doi.org/10.5946/ce.2015.117
Costanian C (2015) Prevalence and factors associated with irritable bowel syndrome among university students in Lebanon: findings from a cross-sectional study. World J Gastroenterol 21(12):3628. https://doi.org/10.3748/wjg.v21.i12.3628
Cui B, Xu F, Zhang F (2016) Methodology, not concept of fecal microbiota transplantation, affects clinical findings. Gastroenterology 150(1):285–286. https://doi.org/10.1053/j.gastro.2015.05.065
Cunha AF, Acurcio LB, Assis BS, Oliveira DLS, Leite MO, Cerqueira MMOP, Souza MR (2013) In vitro probiotic potential of Lactobacillus spp. isolated from fermented milks. Arq Bras Med Vet Zootec 65(6):1876–1882. https://doi.org/10.1590/S0102-09352013000600040
Dalal SR, Chang EB (2014) The microbial basis of inflammatory bowel diseases. J Clin Investig 124(10):4190–4196. https://doi.org/10.1172/JCI72330
Daliri EB-M, Lee BH (2015) New perspectives on probiotics in health and disease. Food Sci Human Wellness 4(2):56–65. https://doi.org/10.1016/j.fshw.2015.06.002
De Filippis F, Vitaglione P, Cuomo R, Berni Canani R, Ercolini D (2018) Dietary interventions to modulate the gut microbiome—how far away are we from precision medicine. Inflamm Bowel Dis 00(00):1–13. https://doi.org/10.1093/ibd/izy080
de Groot PF, Frissen MN, de Clercq NC, Nieuwdorp M (2017) Fecal microbiota transplantation in metabolic syndrome: history, present and future. Gut Microbes 8(3):253–267. https://doi.org/10.1080/19490976.2017.1293224
de Sousa Moraes LF, Grzeskowiak LM, de Sales Teixeira TF, do Carmo Gouveia Peluzio M (2014) Intestinal microbiota and probiotics in celiac disease. Clin Microbiol Rev 27(3):482–489. https://doi.org/10.1128/CMR.00106-13
Derrien M, van Hylckama Vlieg JET (2015) Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol 23(6):354–366. https://doi.org/10.1016/j.tim.2015.03.002
Derwa Y, Gracie DJ, Hamlin PJ, Ford AC (2017) Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 46(4):389–400. https://doi.org/10.1111/apt.14203
Dimidi E, Christodoulides S, Scott SM, Whelan K (2017) Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation. Adv Nutr 8(3):484–494. https://doi.org/10.3945/an.116.014407
Distrutti E, Monaldi L, Ricci P, Fiorucci S (2016) Gut microbiota role in irritable bowel syndrome: new therapeutic strategies. World J Gastroenterol 22(7):2219–2241. https://doi.org/10.3748/wjg.v22.i7.2219
Druart C, Alligier M, Salazar N, Neyrinck AM, Delzenne NM (2014) Modulation of the gut microbiota by nutrients with prebiotic and probiotic properties. Adv Nutr 5(5):624S–633S. https://doi.org/10.3945/an.114.005835
El-Tayeby H, Emara K, Ghoneem H, Zayda A (2017) Results of using the Ilizarov method for correction of complex foot and ankle deformities in skeletally mature patients:310–315. https://doi.org/10.4103/mmj.mmj
Elavarasi V (2014) Screening and characterization of Weissella cibaria isolated from food source for probiotic properties. Int J Comput Appl:29–32
Elli M, Cattivelli D, Soldi S, Bonatti M, Morelli L (2008) Evaluation of prebiotic potential of refined Psyllium (Plantago ovata) fiber in healthy women. 42(September):174–176
Epidemiology D (2004) Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology:1504–1517. https://doi.org/10.1053/j.gastro.2004.01.063
Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A 110(22):9066–9071. https://doi.org/10.1073/pnas.1219451110
Evrensel A, Ceylan ME (2016) Fecal microbiota transplantation and its usage in neuropsychiatric disorders. Clin Psychopharmacol Neurosci 14(3):231–237. https://doi.org/10.9758/cpn.2016.14.3.231
Fernández L, Langa S, Martín V, Maldonado A, Jiménez E, Martín R, Rodríguez JM (2013) The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res 69(1):1–10. https://doi.org/10.1016/j.phrs.2012.09.001
Ferreira RBR, Antunes LCM, Finlay BB (2010) Should the human microbiome be considered when developing vaccines? PLoS Pathog 6(11):e1001190. https://doi.org/10.1371/journal.ppat.1001190
Fijan S (2014) Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health 11:4745–4767. https://doi.org/10.3390/ijerph110504745
Florou-Paneri P, Christaki E, Bonos E (2013) Lactic acid Bacteria as source of functional ingredients. In: Lactic acid bacteria-R & D for food, health and livestock purposes, pp 589–614. https://doi.org/10.5772/47766
Fontana L, Bermudez-Brito M, Plaza-Diaz J, Muñoz-Quezada S, Gil A (2013) Sources, isolation, characterisation and evaluation of probiotics. Br J Nutr 109(Suppl. 2). https://doi.org/10.1017/S0007114512004011
Fontana L, Bermudez-Brito M, Plaza-Diaz J, Muñoz-Quezada S, Gil A (2014) Erratum: Sources, isolation, characterisation and evaluation of probiotics-corrigendum (British Journal of nutrition (2013) 109:2 (S35-50) DOI: 10.1017/S0007114512004011). Br J Nutr 111(4):760. https://doi.org/10.1017/S0007114513003127
Forbes WP, Pharm D, Study T (2011) Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 364(1):22–32
Francisco S (2012) Impact of a resistant dextrin on intestinal ecology: how altering the digestive ecosystem with NUTRIOSE ®, a soluble fibre with prebiotic properties, may be beneficial for health. J Int Med Res 40(1):211–224. https://doi.org/10.1177/147323001204000122
Fuller R, Raibaud P, Rowland IR, Berg RD, Hentges DJ, Freter R et al (1992) Probiotics: the scientific basis. https://doi.org/10.1007/978-94-011-2364-8
Gavin A, Ar KO (1977) Microbiological characterization of human milk 1. J Food Prot 40(9):614–616
Ghattargi VC, Gaikwad MA, Meti BS, Nimonkar YS, Dixit K, Prakash O et al (2018a) Comparative genome analysis reveals key genetic factors associated with probiotic property in Enterococcus faecium strains. BMC Genomics 19(1):652. https://doi.org/10.1186/s12864-018-5043-9
Ghattargi VC, Nimonkar YS, Burse SA, Davray D, Kumbhare SV, Shetty SA et al (2018b) Genomic and physiological analyses of an indigenous strain, Enterococcus faecium 17OM39. Funct Integr Genomics 18(4):385–399. https://doi.org/10.1007/s10142-018-0596-x
Ghose C (2013) Clostridium difficile infection in the twenty-first century. Emerg Microbes Infect 2(9):e62. https://doi.org/10.1038/emi.2013.62
Ghosh S (2004) Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut 53(5):620–622. https://doi.org/10.1136/gut.2003.034249
Glanville J, King S, Guarner F, Hill C, Sanders ME (2015) A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union. Nutr J 14:16. https://doi.org/10.1186/s12937-015-0004-5
Gogineni VK (2013) Probiotics: history and evolution. J Anc Dis Prev Remedies 01(02):1–7. https://doi.org/10.4172/2329-8731.1000107
Grover S, Rashmi H, Srivastava A, Batish V (2012) Probiotics for human health – new innovations and emerging trends. Gut Pathog 4(1):15. https://doi.org/10.1186/1757-4749-4-15
Gupta VK, Paul S, Dutta C (2017) Geography, ethnicity or subsistence-specific variations in human microbiome composition and diversity. Front Microbiol 8(JUN). https://doi.org/10.3389/fmicb.2017.01162
Hassanzadazar H, Ehsani A, Mardani K, Hesari J (2012) Investigation of antibacterial, acid and bile tolerance properties of lactobacilli isolated from Koozeh cheese. Vet Res Forum 3(3):181–185
Health H (2017) Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9):1021. https://doi.org/10.3390/nu9091021
Hemarajata P, Versalovic J (2013) Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Ther Adv Gastroenterol 6(1):39–51. https://doi.org/10.1177/1756283X12459294
Hickson M (2011) Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Ther Adv Gastroenterol 4(3):185–197. https://doi.org/10.1177/1756283X11399115
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al (2014) Expert consensus document: the international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506–514. https://doi.org/10.1038/nrgastro.2014.66
Hoffmann DE (2017) Improving regulation of microbiota transplants. HHS Public Access 20(4):1390–1391. https://doi.org/10.1017/S1092852915000371.Neuroimaging
Hoffmann DE, Palumbo FB, Ravel J, Rowthorn V, von Rosenvinge E (2017) A proposed definition of microbiota transplantation for regulatory purposes. Gut Microbes 8(3):208–213. https://doi.org/10.1080/19490976.2017.1293223
Horvath A, Dziechciarz P, Szajewska H (2011) Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood. Aliment Pharmacol Ther 33(12):1302–1310. https://doi.org/10.1111/j.1365-2036.2011.04665.x
Hurtado JA, Maldonado-Lobón JA, Díaz-Ropero MP, Flores-Rojas K, Uberos J, Leante JL et al (2017) Oral administration to nursing women of Lactobacillus fermentum CECT5716 prevents lactational mastitis development: a randomized controlled trial. Breastfeed Med 12(4):202–209. https://doi.org/10.1089/bfm.2016.0173
Issa I, Moucari R (2014) Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol 20(47):17788–17795. https://doi.org/10.3748/wjg.v20.i47.17788
Jabbar, A., & Wright, R. A. (2003). Gastroenteritis and antibiotic-associated diarrhea. Primary care – clinics in office practice Philadelphia: W.B. Saunders, 30(1), 63–80. https://doi.org/10.1016/S0095-4543(02)00060-X
Jiménez E, Fernández L, Maldonado A, Martín R, Olivares M, Xaus J, Rodríguez JM (2008) Oral Administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl Environ Microbiol 74(15):4650–4655. https://doi.org/10.1128/AEM.02599-07
Johan S, Bakken TB (2011) Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 9(12):1044–1049. https://doi.org/10.1016/j.cgh.2011.08.014.Treating
John SM, Deeseenthum S (2015) Properties and benefits of kefir – a review. Songklanakarin J Sci Technol 37(3):275–282
Johnsen PH, Hilpüsch F, Cavanagh JP, Leikanger IS, Kolstad C, Valle PC, Goll R (2018) Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial:8–10. https://doi.org/10.1016/S2468-1253(17)30338-2
Jose N, Bunt C, Hussain M (2015) Comparison of microbiological and probiotic characteristics of lactobacilli isolates from dairy food products and animal rumen contents. Microorganisms 3(2):198–212. https://doi.org/10.3390/microorganisms3020198
Jump RL (2013) Clostridium difficile infection in older adults. Aging Health 9(4):403–414. https://doi.org/10.2217/ahe.13.37
Kali A (2015) Human microbiome engineering: the future and beyond. J Clin Diagn Res 9(9):1–4. https://doi.org/10.7860/JCDR/2015/14946.6570
Kali A (2016) Psychobiotics: an emerging probiotic in psychiatric practice. Biom J 39(3):223–224. https://doi.org/10.1016/j.bj.2015.11.004
Kappelman MD, Shiman SLR, Kleinman KEN, Ollendorf DAN, Bousvaros A, Grand RJ, Finkelstein JA (2007) The prevalence and geographic distribution of Crohn’s disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol:1424–1429. https://doi.org/10.1016/j.cgh.2007.07.012
Kelly CR, Kahn S, Kashyap P, Laine L, Rubin D, Atreja A et al (2015) Update on FMT 2015: indications, methodologies, mechanisms and outlook. Gastroenterology 149(1):223–237. https://doi.org/10.1053/j.gastro.2015.05.008.Update
Kim KW, Kang S, Woo S, Park O, Ahn KB, Song K et al (2017a) Lipoteichoic acid of probiotic Lactobacillus plantarum attenuates poly I:C-induced IL-8 production in porcine intestinal epithelial cells. Front Microbiol 8(September):1–8. https://doi.org/10.3389/fmicb.2017.01827
Kim SJ, Park SH, Sin HS, Jang SH, Lee SW, Kim SY et al (2017b) Hypocholesterolemic effects of probiotic mixture on diet-induced hypercholesterolemic rats. Nutrients 9(3):1–10. https://doi.org/10.3390/nu9030293
Kozak K, Charbonneau D, Sanozky-Dawes R, Klaenhammer T (2015) Characterization of bacterial isolates from the microbiota of mothers’ breast milk and their infants. Gut Microbes 6(6):341–351. https://doi.org/10.1080/19490976.2015.1103425
Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A et al (2012) Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. https://doi.org/10.1155/2012/902917
Kumbhare SV, Kumar H, Chowdhury SP, Dhotre DP, Patil NP, Patil RH et al (2017) OPEN a cross-sectional comparative study of gut bacterial community of Indian and Finnish children, (August). Sci Rep:1–13. https://doi.org/10.1038/s41598-017-11215-y
La Fata G, Weber P, Mohajeri MH (2018) Probiotics and the gut immune system: indirect regulation. Probiotics Antimicrob Proteins 10(1):11–21. https://doi.org/10.1007/s12602-017-9322-6
Lam YY, Zhang C, Zhao L (2018) Causality in dietary interventions—building a case for gut microbiota. Genome Med 10(1):62. https://doi.org/10.1186/s13073-018-0573-y
Langdon A, Crook N, Dantas G (2016) The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 8(1):39. https://doi.org/10.1186/s13073-016-0294-z
Lee CM, Sieo CC, Wong CMVL, Abdullah N, Ho YW (2008) Sequence analysis of 16S rRNA gene and 16S–23S rRNA gene intergenic spacer region for differentiation of probiotics Lactobacillus strains isolated from the gastrointestinal tract of chicken. Ann Microbiol 58(1):133–140. https://doi.org/10.1007/BF03179457
Leite AMO, Miguel MAL, Peixoto RS, Ruas-Madiedo P, Paschoalin VMF, Mayo B, Delgado S (2015) Probiotic potential of selected lactic acid bacteria strains isolated from Brazilian kefir grains. J Dairy Sci 98(6):3622–3632. https://doi.org/10.3168/jds.2014-9265
Hung LP, Aoi W et al (2014) The astaxanthin-induced improvement in lipid metabolism during exercise is mediated by PGC-1alfa increase in skeletal muscle. J Clin Biochen Nutr 54(March):86–89. https://doi.org/10.3164/jcbn.13
Liu X, Cao S, Zhang X (2015) Modulation of gut microbiota–brain Axis by probiotics, prebiotics, and diet. J Agric Food Chem 63(36):7885–7895. https://doi.org/10.1021/acs.jafc.5b02404
Loh G, Blaut M (2012) Role of commensal gut bacteria in inflammatory bowel diseases© 2012 Landes bioscience. Gut Microbes 3(6):544–555. https://doi.org/10.4161/gmic.22156
Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268–1274
Lyra A, Krogius-kurikka L, Nikkilä J, Malinen E, Kajander K, Kurikka K, Korpela R (2010) Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterol (10):110. https://doi.org/10.1186/1471-230X-10-110
Mackowiak PA (2013) Recycling Metchnikoff: probiotics, the intestinal microbiome and the quest for long life. Front Public Health 1(November):1–3. https://doi.org/10.3389/fpubh.2013.00052
Markowiak P, Slizewska K (2017) Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9):1021. https://doi.org/10.3390/nu9091021
Martín R, Jiménez E, Heilig H, Fernández L, Marín ML, Zoetendal EG, Rodríguez JM (2009) Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCR. Appl Environ Microbiol 75(4):965–969. https://doi.org/10.1128/AEM.02063-08
Martinello F, Roman CF, De Souza PA (2017) Effects of probiotic intake on intestinal Bifidobacteria of celiac patients. Arq Gastroenterol 54(2):85–90. https://doi.org/10.1590/s0004-2803.201700000-07
Matricon J, Barnich N, Ardid D (2010) Immunopathogenesis of inflammatory bowel disease. Self/Nonself 1(4):299–309. https://doi.org/10.4161/self.1.4.13560
Mazurak N, Broelz E, Storr M, Enck P (2015) Probiotic therapy of the irritable bowel syndrome: why is the evidence still poor and what can be done about it? J Neurogastroenterol Motil 21(4):471–485. https://doi.org/10.5056/jnm15071
McFarland LV, Ozen M, Dinleyici EC, Goh S (2016) Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol 22(11):3078–3104. https://doi.org/10.3748/wjg.v22.i11.3078
McFarland LV (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101(4):812–822. https://doi.org/10.1111/j.1572-0241.2006.00465.x
Mearin F, Spiller RC (2006) Functional bowel disorders, pp 1480–1491. https://doi.org/10.1053/j.gastro.2005.11.061
Mennigen R, Bruewer M (2009) Effect of probiotics on intestinal barrier function. Ann N Y Acad Sci 1165:183–189. https://doi.org/10.1111/j.1749-6632.2009.04059.x
Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, Prajapati J (2015) Probiotics as potential antioxidants: a systematic review. J Agric Food Chem 63(14):3615–3626. https://doi.org/10.1021/jf506326t
Misra S, Mohanty D (2017) Psychobiotics: a new approach for treating mental illness? Crit Rev Food Sci Nutr 0(0):1–7. https://doi.org/10.1080/10408398.2017.1399860
Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C et al (2015a) Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149(1):102–109. https://doi.org/10.1053/j.gastro.2015.04.001
Moayyedi P, Surette MG, Kim PT, Libertucci J, Wolfe M, Onischi C et al (2015b) With active ulcerative colitis in a randomized controlled trial. Gastroenterology 149(1):102–109.e6. https://doi.org/10.1053/j.gastro.2015.04.001
Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, Managlia E et al (2011) Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci 108(Supplement_1):4623–4630. https://doi.org/10.1073/pnas.1005066107
Murphy K, Curley D, O’Callaghan TF, O’Shea C-A, Dempsey EM, O’Toole PW et al (2017) The composition of human Milk and infant Faecal microbiota over the first three months of life: a pilot Study. Sci Rep 7(October 2016):40597. https://doi.org/10.1038/srep40597
Nakaya HI, Bruna-Romero O (2015) Is the gut microbiome key to modulating vaccine efficacy? Expert Rev Vaccines 14(6):777–779. https://doi.org/10.1586/14760584.2015.1040395
Nanthakumar NN, Fusunyan RD, Sanderson I, Walker W a (2000) Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A 97(11):6043–6048. https://doi.org/10.1073/pnas.97.11.6043
Nicolucci AC, Reimer RA (2017) Prebiotics as a modulator of gut microbiota in paediatric obesity. Pediatr Obes 12(4):265–273. https://doi.org/10.1111/ijpo.12140
O’Toole PW, Marchesi JR, Hill C (2017) Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol 2(5):17057. https://doi.org/10.1038/nmicrobiol.2017.57
Odamaki T, Kato K, Sugahara H, Hashikura N, Takahashi S, Xiao JZ et al (2016) Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 16(1):1–12. https://doi.org/10.1186/s12866-016-0708-5
Ottman N, Smidt H, de Vos WM, Belzer C (2012) The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol 2(August):1–11. https://doi.org/10.3389/fcimb.2012.00104
Ozen M, Dinleyici EC (2015) The history of probiotics: the untold story. Benefic Microbes 6(2):159–165. https://doi.org/10.3920/BM2014.0103
Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics – a review. J Food Sci Technol 52(12):7577–7587. https://doi.org/10.1007/s13197-015-1921-1
Parvez S, Malik KA, Ah Kang S, Kim H-Y (2006) Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 100(6):1171–1185. https://doi.org/10.1111/j.1365-2672.2006.02963.x
Patel K, Patel A, Hawes D, Shah J, Shah K (2018) Faecal microbiota transplantation: looking beyond clostridium difficile infection at inflammatory bowel disease. Gastroenterol Hepatol Bed Bench 11(1):1–8
Pélerin F, Desreumaux P (2016) Probiotic yeast therapy for irritable bowel syndrome. J Neurogastroenterol Motil 22(3):542–542. https://doi.org/10.5056/jnm16075
Penesyan A, Gillings M, Paulsen I (2015) Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules 20(4):5286–5298. https://doi.org/10.3390/molecules20045286
Pereira DI a, Mccartney AL, Gibson GR (2003) An in vitro Study of the probiotic potential of a bile-salt-hydrolyzing. Society 69(8):4743–4752. https://doi.org/10.1128/AEM.69.8.4743
Pérez-Cano FJ, Dong H, Yaqoob P (2010) In vitro immunomodulatory activity of Lactobacillus fermentum CECT5716 and Lactobacillus salivarius CECT5713: two probiotic strains isolated from human breast milk. Immunobiology 215(12):996–1004. https://doi.org/10.1016/j.imbio.2010.01.004
Prabhurajeshwar C, Chandrakanth RK (2017) Probiotic potential of lactobacilli with antagonistic activity against pathogenic strains: an in vitro validation for the production of inhibitory substances. Biom J 40(5):270–283. https://doi.org/10.1016/j.bj.2017.06.008
Prado MR, Bland�n LM, Vandenberghe LPS, Rodrigues C, Castro GR, Thomaz-Soccol V, Soccol CR (2015) Milk kefir: composition, microbial cultures, biological activities, and related products. Front Microbiol 6(OCT):1–10. https://doi.org/10.3389/fmicb.2015.01177
Praharaj I, John SM, Bandyopadhyay R, Kang G (2015) Probiotics, antibiotics and the immune responses to vaccines. Philos Trans R Soc, B 370(1671):20140144–20140144. https://doi.org/10.1098/rstb.2014.0144
Rajilić-Stojanović M, de Vos WM (2014) The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38(5):996–1047. https://doi.org/10.1111/1574-6976.12075
Reid G (2016) Probiotics: definition, scope and mechanisms of action. Best Pract Res Clin Gastroenterol 30(1):17–25. https://doi.org/10.1016/j.bpg.2015.12.001
Ridaura VK, Faith JJ, Rey FE, Cheng J, Alexis E, Kau AL et al (2014) Cultured gut microbiota from twins discordant for obesity modulate adiposity and metabolic phenotypes in mice. Science 341(6150):1–22. https://doi.org/10.1126/science.1241214.Cultured
Riddle MS, Dupont HL, Connor BA (2016) ACG clinical guideline: diagnosis, treatment, and prevention of acute diarrheal infections in adults. Am J Gastroenterol 111(5):602–622. https://doi.org/10.1038/ajg.2016.126
Ritze Y, Bárdos G, Claus A, Ehrmann V, Bergheim I, Schwiertz A, Bischoff SC (2014) Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice. PLoS One 9(1):e80169. https://doi.org/10.1371/journal.pone.0080169
Rodriguez JM (2014) The origin of human Milk Bacteria: is there a bacterial Entero-mammary pathway during late pregnancy and lactation? Adv Nutr: An Int Rev J 5(6):779–784. https://doi.org/10.3945/an.114.007229
Rubin DC, Shaker A, Levin MS (2012) Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 3(MAY):1–10. https://doi.org/10.3389/fimmu.2012.00107
Ruiz L, Margolles A, Sánchez B (2013) Bile resistance mechanisms in Lactobacillus and Bifidobacterium. Front Microbiol 4(DEC):1–8. https://doi.org/10.3389/fmicb.2013.00396
Saez-Lara MJ, Gomez-Llorente C, Plaza-Diaz J, Gil A (2015) The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. Biomed Res Int. https://doi.org/10.1155/2015/505878
Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EMM, Sartor RB et al (2013) An update on the use and investigation of probiotics in health and disease. Gut 62(5):787–796. https://doi.org/10.1136/gutjnl-2012-302504
Sarkar A, Lehto SM, Harty S, Dinan TG, Cryan JF, Burnet PWJ (2016) Psychobiotics and the manipulation of Bacteria–gut–brain signals. Trends Neurosci 39(11):763–781. https://doi.org/10.1016/j.tins.2016.09.002
Saulnier DMA, Spinler JK, Gibson GR (2010) NIH Public Access 20(2):135–141. https://doi.org/10.1016/j.copbio.2009.01.002.Mechanisms
Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE (2006) Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6(6):374–382. https://doi.org/10.1016/S1473-3099(06)70495-9
Sbahi H, Di Palma JA (2016) Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol 3(1):e000087. https://doi.org/10.1136/bmjgast-2016-000087
Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I et al (2013) Gut microbial Flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int 2013:1–9. https://doi.org/10.1155/2013/435268
Schutte ML (2013) Isolation and identification of the microbial consortium present in fermented milks from Sub-Saharan Africa. Msc thesis, (March), p 116
Sheil B, Shanahan F, O’Mahony L (2007) Probiotic effects on inflammatory bowel disease. J Nutr 137(3 Suppl 2):819S–824S. https://doi.org/10.1093/jn/137.3.819S
Shewale R, Pravin S, CD K, Singh A (2014) Selection criteria for probiotics. Int J Probiotic Prebiotics:9
Shin J-H, Sim M, Lee J-Y, Shin D-M (2016) Lifestyle and geographic insights into the distinct gut microbiota in elderly women from two different geographic locations. J Physiol Anthropol 35(1):31. https://doi.org/10.1186/s40101-016-0121-7
Singh RP, Kothari V, Koringa PG, Singh SP (2017) Understanding host-microbiome interactions – an omics approach: omics of host-microbiome association. In: Understanding host-microbiome interactions – an omics approach: omics of host-microbiome association, pp 1–368. https://doi.org/10.1007/978-981-10-5050-3
Slavin J (2013) Fiber and prebiotics: mechanisms and Health benefits. Nutrients 5(4):1417–1435. https://doi.org/10.3390/nu5041417
Smits LP, Bouter KEC, De Vos WM, Borody TJ, Nieuwdorp M (2013) Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145(5):946–953. https://doi.org/10.1053/j.gastro.2013.08.058
Soccol CR, Vandenberghe LP d S, Spier MR, Medeiros ABP, Yamaguishi CT, De Dea Lindner J et al (2010) The potential of probiotics: a review. Food Technol Biotechnol 48(4):413–434
Sornplang P, Piyadeatsoontorn S (2016) Probiotic isolates from unconventional sources: a review. J Anim Sci Technol 58:26. https://doi.org/10.1186/s40781-016-0108-2
Starr J (2005) Clostridium difficile associated diarrhoea: diagnosis and treatment. BMJ 331(7515):498–501. https://doi.org/10.1136/bmj.331.7515.498
Sun Z, Liu W, Gao W, Yang M, Zhang J, Wu L et al (2010) Identification and characterization of the dominant lactic acid bacteria from kurut: the naturally fermented yak milk in Qinghai, China. J Gen Appl Microbiol 56(1):1–10. https://doi.org/10.2323/jgam.56.1
Šušković J, Kos B, Beganović J, Pavunc AL, Habjanič K, Matoć S (2010) Antimicrobial activity - the most important property of probiotic and starter lactic acid bacteria. Food Technol Biotechnol 48(3):296–307. https://doi.org/10.1128/MMBR.67.3.429
Sweeney TE, Morton JM, Surgery MI (2015) He human gut microbiome A review of the effect of obesity and surgically induced weight loss. JAMA Surg 148(6):563–569. https://doi.org/10.1001/jamasurg.2013.5.The
Ayichew T, Belete A, Alebachew T, Tsehaye H, Berhanu H, Minwuyelet A (2017) Bacterial probiotics their importances and limitations: a review. J Nutr Health Sci 4(2). https://doi.org/10.15744/2393-9060.4.202
Tamang JP, Watanabe K, Holzapfel WH (2016) Review: diversity of microorganisms in global fermented foods and beverages. Front Microbiol 7(MAR). https://doi.org/10.3389/fmicb.2016.00377
Tannock GW (2004) A special fondness for lactobacilli. Appl Environ Microbiol 70(6):3189–3194. https://doi.org/10.1128/AEM.70.6.3189-3194.2004
Tareb R, Bernardeau M, Gueguen M, Vernoux JP (2013) In vitro characterization of aggregation and adhesion properties of viable and heat-killed forms of two probiotic Lactobacillus strains and interaction with foodborne zoonotic bacteria, especially campylobacter jejuni. J Med Microbiol 62(PART4):637–649. https://doi.org/10.1099/jmm.0.049965-0
Tavakkoli A, Green PH (2013) Probiotic therapy for celiac disease. J Clin Gastroenterol 47(2):101–103. https://doi.org/10.1097/MCG.0b013e31827b507d
Tham DM, Gardner CD, Haskell WL (2011) Potential Health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83(7):2223–2235. https://doi.org/10.1210/jc.83.7.2223
Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM et al (2010) Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 105(10):2218–2227. https://doi.org/10.1038/ajg.2010.218
Umu ÖCO, Rudi K, Diep DB (2017) Modulation of the gut microbiota by prebiotic fibres and bacteriocins. Microb Ecol Health Dis 28(1):1348886. https://doi.org/10.1080/16512235.2017.1348886
Uwlfoh SS, Dgglwlrqdo RU, Derxw L, Duwlfoh W, Lewin RA (2016) More Merde 44(4):594–607
Varankovich NV, Nickerson MT, Korber DR (2015) Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front Microbiol 6(JUN):1–14. https://doi.org/10.3389/fmicb.2015.00685
Varma P, Dinesh KR, Menon KK, Biswas R (2010) Lactobacillus Fermentum isolated from human colonic mucosal biopsy inhibits the growth and adhesion of enteric and foodborne pathogens. J Food Sci 75(9):M546–M551. https://doi.org/10.1111/j.1750-3841.2010.01818.x
Vélez MP, De Keersmaecker SCJ, Vanderleyden J (2007) Adherence factors of Lactobacillus in the human gastrointestinal tract. FEMS Microbiol Lett 276(2):140–148. https://doi.org/10.1111/j.1574-6968.2007.00908.x
Ventura M, Turroni F, van Sinderen D (2015) Bifidobacteria of the human gut. In: Diet-microbe interactions in the gut. Elsevier, pp 41–51. https://doi.org/10.1016/B978-0-12-407825-3.00004-6
Videlock EJ, Cremonini F (2012) Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 35(12):1355–1369. https://doi.org/10.1111/j.1365-2036.2012.05104.x
Vieira AT, Teixeira MM, Martins FS (2013) The role of probiotics and prebiotics in inducing gut immunity. Front Immunol 4(DEC):1–12. https://doi.org/10.3389/fimmu.2013.00445
Voreades N, Kozil A, Weir TL (2014) Diet and the development of the human intestinal microbiome. Front Microbiol 5(SEP):1–9. https://doi.org/10.3389/fmicb.2014.00494
Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman JFWM et al (2012) Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143(4):913–916.e7. https://doi.org/10.1053/j.gastro.2012.06.031
Walker WA (2008) Mechanisms of action of probiotics. Clin Infect Dis 46(s2):S87–S91. https://doi.org/10.1086/523335
Wang Y, Wu Y, Wang Y, Xu H, Mei X, Yu D et al (2017) Antioxidant properties of probiotic bacteria. Nutrients 9(5). https://doi.org/10.3390/nu9050521
Weiss K, Lentnek A, Golan Y, Gorbach S, Sears P, Shue YK et al (2011) Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 364(5):422–431
Wistrom J (2001) Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47(1):43–50. https://doi.org/10.1093/jac/47.1.43
Meng-Que Xu, (2015) Fecal microbiota transplantation broadening its application beyond intestinal disorders. World Journal of Gastroenterology 21 (1):102
Yan F, Polk DB (2014) Lactobacillus rhamnosus GG: an updated strategy to use microbial products to promote Health. Funct Food Rev 4(2):77–84
Yu Q, Yuan L, Deng J, Yang Q (2015) Lactobacillus protects the integrity of intestinal epithelial barrier damaged by pathogenic bacteria. Front Cell Infect Microbiol 5(March):1–7. https://doi.org/10.3389/fcimb.2015.00026
Zeng XQ, Pan DD, Guo YX (2010) The probiotic properties of Lactobacillus buchneri P2. J Appl Microbiol 108(6):2059–2066. https://doi.org/10.1111/j.1365-2672.2009.04608.x
Zhang F, Luo W, Shi Y, Fan Z, Ji G (2012) Should we standardize the 1,700-year-old fecal microbiota transplantation. Am J Gastroenterol 107(11):1755. https://doi.org/10.1038/ajg.2012.251
Zhang H, Cai Y (2014) Lactic acid bacteria: fundamentals and practice. https://doi.org/10.1007/978-94-017-8841-0
Zheng J, Xiao X, Zhang Q, Mao L, Yu M, Xu J, Wang T (2017) The placental microbiota is altered among subjects with gestational diabetes mellitus: a spilot study. Front Physiol 8(SEP):1–12. https://doi.org/10.3389/fphys.2017.00675
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ghattargi, V.C., Sape, K., Kumbhare, S.V., Shouche, Y.S. (2019). Mining Human Microbiome for Therapeutics. In: Satyanarayana, T., Johri, B., Das, S. (eds) Microbial Diversity in Ecosystem Sustainability and Biotechnological Applications. Springer, Singapore. https://doi.org/10.1007/978-981-13-8315-1_18
Download citation
DOI: https://doi.org/10.1007/978-981-13-8315-1_18
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8314-4
Online ISBN: 978-981-13-8315-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)